What impact do side effects have on elderly chronic myeloid leukemia (CML) patients?
Long-term follow-up: AML17 trial of ATO and ATRA vs the standard of care in APL
Alan K. Burnett
The use of trastuzumab and biosimilars in the treatment of breast cancer
Best treatment strategy for FLT3 ITD AML
The origin and work of the International Workshop on Chronic Lymphocytic Leukemia (iwCLL)